Predicting Mortality for Patients Eligible for Extracorporeal Membrane Oxygenation for COVID-19.

Gannon, Whitney D; Stokes, John W; Gong, Wu; Lindsell, Christopher J; Tonna, Joseph E; Bacchetta, Matthew; Rice, Todd W; Semler, Matthew W; Casey, Jonathan D

Gannon, Whitney D; Stokes, John W; Gong, Wu; Lindsell, Christopher J; Tonna, Joseph E; Bacchetta, Matthew; Rice, Todd W; Semler, Matthew W; Casey, Jonathan D.

Afiliación

Gannon WD; Vanderbilt University Medical Center Nashville, Tennessee.
Stokes JW; Vanderbilt University Medical Center Nashville, Tennessee.
Gong W; Vanderbilt University Medical Center Nashville, Tennessee.
Lindsell CJ; Vanderbilt University Medical Center Nashville, Tennessee.
Tonna JE; University of Utah Health Salt Lake City, Utah.
Bacchetta M; Vanderbilt University Medical Center Nashville, Tennessee.
Rice TW; Vanderbilt University Medical Center Nashville, Tennessee.
Semler MW; Vanderbilt University Medical Center Nashville, Tennessee.
Casey JD; Vanderbilt University Medical Center Nashville, Tennessee.

Am J Respir Crit Care Med ; 206(5): 628-632, 2022 09 01.

Article en En | MEDLINE | ID: mdl-35549663

Asunto(s)

COVID-19; Oxigenación por Membrana Extracorpórea; Síndrome de Dificultad Respiratoria; Mortalidad Hospitalaria; Humanos; Respiración Artificial; Estudios Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / Oxigenación por Membrana Extracorpórea / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google